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QM/MM modeling of Mexiletine N -hydroxylation by CYP1A2
Abstract
The mechanism of cytochrome P450(CYP)-catalyzed hydroxylation of primary amines
is currently unclear, and is relevant to drug metabolism. Previous small model calcula-
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tions have suggested two possible mechanisms: directN -oxidation and H-abstraction/rebound.
We have modeled the N -hydroxylation of (R)-mexiletine in CYP1A2 with hybrid quan-
tum mechanics/molecular mechanics (QM/MM) methods, providing a more detailed
and realistic model. Multiple reaction barriers have been calculated at the QM(B3LYP-
D)/MM(CHARMM27) level for the direct N -oxidation and H-abstraction/rebound
mechanisms. Our calculated barriers indicate that the direct N -oxidation mechanism
is preferred and proceeds via the doublet spin state of Compound I. Molecular dynam-
ics simulations indicate that the presence of an ordered water molecule in the active
site assists in the binding of mexiletine in the active site, but is not a prerequisite for
reaction via either mechanism. Several active site residues play a role in the binding
of mexiletine in the active site, including Thr124 and Phe226. This work reveals key
details in the N -hydroxylation of mexiletine and further demonstrates that mechanistic
studies using QM/MM methods are useful for understanding drug metabolism.
Introduction
The cytochromes P450 (CYPs) play an important role in drug metabolism:1,2 indeed, over
70 % of all drugs are metabolized by one of four CYPs (3A4, 2C9, 2D6, 1A2) at some stage in
their metabolic pathway.3,4 The metabolism of drugs by CYPs can lead to adverse reactions,5
and hence predictions of CYP metabolism will help in the design of safer medicines. To
enable accurate predictions, an understanding of the reaction mechanisms is important, as
the models used to estimate reactivities depend on this.6 The mechanisms of CYPs are
difficult to study experimentally, due to their high activity, and the instability of their active
species, Compound I (Cpd I).7,8 Several mechanistic studies have been performed using
quantum mechanics/molecular mechanics (QM/MM) for CYP isoforms.9,10 However, these
studies have been mostly performed on model substrates, and relatively few pharmaceutical
compounds have so far been modeled.11–16
CYP1A2 is involved in drug metabolism, and is found in the endoplasmic reticulum of
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liver cells, constituting 12% of the CYPs in the liver.1 Substrates of CYP1A2 are typically
hydrophobic, with high logP values,17,18 and include caffeine, clozapine, theophylline and
mexiletine.2 CYP1A2 also metabolizes the endogenous substrates estrone and 17-estradiol.19
Mexiletine (1) is used to treat ventricular dysrhythmias,20,21 and is administered in a racemic
mixture of R- and S -enantiomers, with the R-enantiomer being slightly more potent.22 Mex-
iletine has a narrow therapeutic index23,24 and is metabolized by several CYPs.25 Together
with CYP2E1 and CYP2B6, CYP1A2 is involved in the N-hydroxylation of mexiletine to
form N -hydroxmexiletine (2, Scheme 1).26 The hydroxylation of N -hydroxmexiletine occurs
ten times faster in CYP1A2 for the R-, compared to the S -enantiomer. Hydroxymethylmex-
iletine (3) and p-hydroxymexiletine (4) are also formed during metabolism of mexiletine
by CYP1A2.27 The latter two metabolites, together with m-hydroxymexiletine (5) are also
formed due to metabolism by CYP2D6.25,28 CYP2D6 is known to react with substrates which
contain a basic protonated amine group at a distance of ∼ 7 A˚ from the site of oxidation,29
due to interactions with Glu216 and Asp301, which line the active site and are believed to
be important for substrate binding. CYP1A2 has a known preference for hydrophobic sub-
strates17,18 and therefore it is unlikely that the amine group of mexiletine will be protonated
in the active site of CYP1A2. The NH2 nitrogen of mexiletine is 5-7 A˚ from the known sites
of oxidation in CYP2D6, and may explain why N-hydroxylation is not observed for oxidation
of mexiletine by CYP2D6.
It is important to understand the mechanism behind the formation of hydroxylamines,
such as 2, because some related compounds have been found to be toxic.30 Three possible
mechanisms have been proposed for N-hydroxylation of primary amines by CYPs:31 H-
abstraction followed by rebound, direct N-oxidation followed by rearrangement of the N-
oxide to the hydroxylamine, and direct O-insertion to the N-H bond (Scheme 2). The
H-abstraction/rebound pathway is the widely accepted mechanism for the hydroxylation
of aliphatic carbon atoms,32 and involves the abstraction of a hydrogen atom from the
substrate by Cpd I, forming a radical and a hydroxy-iron complex; the subsequent step
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Scheme 1: Cytochrome P450 mediated metabolism of mexiletine (1) in humans.25–28
is the ‘rebound’ step, whereby the substrate-oxygen bond is formed. This mechanism is
supported by experimental measurement of kinetic isotope effects,7 which to our knowledge
have not been measured for the hydroxylation of amines by CYPs.
The oxidation of primary and secondary amines by Cpd I has previously been studied
in small models by DFT calculations.33,34 The direct insertion of Cpd I ferryl oxygen into
the N-H bond of propan-2-amine was found to be energetically unfavorable, and can thus
be discounted as a mechanism for the N -hydroxylation of primary amines.33 The calculated
energy barriers to the remaining mechanisms were similar to each other, the relative ordering
was found to depend on the value of the dielectric when a polarized continuum model was
applied (direct oxygen insertion was favored in water, H-abstraction/rebound was favored
in protein). A more recent study of propan-2-amine hydroxylation by the same group34
in which the DFT calculations included an empirical dispersion correction, found the H-
abstraction/rebound pathway to be preferred by around 2 kcal/mol. The hydroxylation of
primary aromatic amines has also been recently studied.35 Several proposed mechanisms
were studied using aniline and p-substituted derivatives. The authors concluded that the
most energetically feasible mechanism corresponded to hydrogen abstraction, followed by
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Scheme 2: Proposed mechanisms31 for hydroxylation of primary amine RNH2 by Compound
I: (a) H-abstraction followed by rebound; (b) direct N-oxidation followed by rearrangement;
(c) direct insertion into N-H bond. Previous calculations33 indicate mechanism (c) is not
energetically feasible and hence only mechanisms (a) and (b) are considered in this study.
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rebound. The barrier to hydrogen abstraction was calculated to be 3.7 and 3.9 kcal/mol
for the doublet and quartet spin states of Cpd I, respectively (at the UB3LYP/LACVP-6-
31+G(d,p) level). The possible involvement of electron transfer mechanisms in the oxidation
of amines by CYPs has also been investigated for both aniline35 and tertiary amines,36 and
was found to be unlikely in both cases.
In this study, the mechanism of primary amine hydroxylation by CYPs has been inves-
tigated using a large and detailed CYP1A2:mexiletine complex, constructed using docking
and molecular dynamics simulations. Different binding conformations of mexiletine were
selected and used to calculate multiple QM(B3LYP-D)/MM(CHARMM27) reaction profiles
for the proposed H-abstraction/rebound and direct N -oxidation mechanisms. Our results
suggest that both reaction pathways may contribute towards the reactivity of Cpd I with
primary amines, and we identify important binding interactions between the substrate and
active site of CYP1A2.
Computational details
The initial structure of the enzyme used in the present study was built from a crystal struc-
ture of CYP1A2 (PDB code: 2HI4).37 Docking and molecular dynamics (MD) simulations
were performed prior to QM/MM calculations. Details of these are provided in the support-
ing information (SI). The protocols used are similar to those used previously in QM/MM
modeling of several CYPs.9,12,13,38
The structures from MD simulations were screened before selection as starting models for
QM/MM calculations. The selection criteria used in the screening ensured that mexiletine
was in a ‘reactive’ conformation within the active site, with respect to N -hydroxylation,
thus giving the most representative reaction barriers. This type of conformational screening
has been applied in previous work for the modeling of other P450-catalysed oxidation reac-
tions.12,39 Structures were selected such that the O-H interatomic distance was less than 3
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A˚ and the Fe-O-H angle was between 110 and 130◦, where O and H are the ferryl oxygen of
Cpd I and either one of the amine protons of mexiletine, respectively. In the previous small
model DFT studies of N -hydroxylation,33,34 the barriers to N -oxidation and H-abstraction
were calculated relative to a common starting structure: That in which a hydrogen bond
is present between the Cpd I oxygen and an amine proton, and corresponds to the energy
minimum for the reactant complex. In the present study, direct N -oxidation profiles and
H-abstraction/rebound profiles were calculated using the same starting structures from MD.
QM/MM calculations were performed using the B3LYP functional40–43 for the QM re-
gion, with an empirical correction for dispersion;44 inclusion of dispersion effects has been
shown to improve DFT modeling of P450-catalysed reactions.38,45 The LACVP basis set46
was used for iron and the 6-31G(d) basis set47 for all other QM atoms (denoted herein as
BSI). The CHARMM27 force field48 was used to describe the MM region. The MM calcula-
tions were carried out with Tinker,49 and the QM calculations with Jaguar.50 The coupling
between the QM and MM calculations and the QM/MM minimization was performed with
QoMMMa.51 Additional single point energy calculations were carried out on the B3LYP-
D:6-31G(d)/CHARMM27 optimized geometries for the starting materials, transition states,
intermediates and products, using the LACV3P basis set for iron and 6-311++G(d,p) for all
other atoms (BSII).
The QM region consisted of 64 atoms: mexiletine, a truncated heme group and a thiolate
to represent the Fe-bound cysteine residue. The rest of the atoms in the system were included
in the MM region. Hydrogen ‘link’ atoms were used to cap all of the C-C bonds at the QM-
MM boundary.52 Charges of MM atoms at the QM/MM boundary were set to zero, to avoid
any unphysical effects due to interactions with the link atoms.53
The nine structures selected from the MD trajectories were QM/MM energy minimized
for both the quartet and doublet spin states of Compound I. Reaction pathways were mod-
eled using an adiabatic mapping procedure.12,39 For the direct N -oxidation reaction, a series
of QM/MM energy minimizations was performed with the N-O distance restrained sequen-
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tially to values between 3 A˚ and 1.4 A˚, varied at intervals of 0.2 A˚ (0.1 A˚ and 0.05 A˚ around
the transition state). For the H-abstraction reaction, the same procedure was used for the
O-H distance between 2.2 A˚ and 1 A˚. The structure corresponding to the intermediate for
H-abstraction was QM/MM minimized without reaction coordinate restraints and subse-
quently used as the starting geometry for calculating the rebound step. In this step the
N-O distance was varied between 2.7 A˚ (corresponding to the radical intermediate) to 1.4 A˚
(the product). The product geometry was subsequently energy-minimized without reaction
coordinate constraints. Absolute energies of all stationary points are provided in the SI.
In addition to the individual barriers given below, an overall barrier was calculated by a
Boltzmann-weighted averaging procedure of the calculated barriers, as detailed in previous
work.39 This averaging scheme compensates for the relatively small amount of conformational
sampling in an approximate manner, as it places higher importance on the lower energy
barriers, which are likely to be more representative of the true reactivity of the enzyme.
For multi-step reactions, barriers were calculated for all steps relative to the energy of the
reactant complex (RC).
Single-point calculations were also performed on the stationary points for selected path-
ways using the BP8654,55 and BHandHLYP42,43,46,56 functionals. The energies calculated
using these functionals are provided in the SI. The absolute values of the calculated energy
barriers were found to differ depending on the choice of functional, however, the qualitative
analysis of the barriers is unaffected.
Results and discussion
In order to obtain suitable starting geometries for the QM/MM calculations, MD simulations
were performed from four different docked poses of mexiletine in CYP1A2. In total, over 80
ns of MD data were obtained, yielding over 16,000 structural ‘snapshots’ to use as potential
starting geometries. These snapshots exhibited variation in the orientation of mexiletine
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within the CYP1A2 active site, and different binding modes of mexiletine were observed.
During some sections of the MD simulations, the substrate rotated around such that the
ring fragment was pointing towards the active site. This is consistent with the formation
of multiple metabolites of mexiletine by CYP1A2, as shown in Scheme 1. However, in such
positions, the other oxidation sites were too far away (> 5 A˚) from the Cpd I oxygen for
reaction to occur (for more details see SI). As our aim here is to study the mechanism of
N -hydroxylation, screening of the MD simulations for suitable reactive starting geometries
for QM/MM calculations was required, as described above.
The structures of the reactive poses of mexiletine in the active site of CYP1A2 show
that several residues are involved in the binding of mexiletine (Figure 1). These interactions
include a pi-stacking interaction to Phe226, a hydrogen-bond to the Cpd I oxygen and a
hydrogen bond to Thr124 via a bridging water molecule. The importance of bridging water
molecules and their changing presence in the active site has been noted previously in other
computational studies of CYP reactivity.57,58 The number of water molecules in the active
site varies between simulations and hence the latter interaction is not observed during all
of the simulations. Some frames were observed where the amine proton that is otherwise
hydrogen-bonded to Thr124 forms a hydrogen bond to the ether oxygen of mexiletine. The
hydrogen bond between the amine group of mexiletine and Cpd I ferryl oxygen, as well as
the pi-stacking interaction to Phe226, are maintained. Many more (> 5) water molecules
were observed in the active site cavity during periods of some simulations. When this occurs,
mexiletine is prevented from approaching Cpd I for reaction.
Only three of the four MD simulations yielded suitable starting structures for modeling
N -hydroxylation. These were propagated from three different docking poses (details in the
SI), each of which contained a different binding conformation of mexiletine in the active site
(referred to herein as A, B and C). QM/MM (B3LYP-D/CHARMM27) optimized reactant
complexes, derived from each of these simulations (A, B and C) are displayed in Figure 2.
Nine QM/MM energy barriers were obtained for the H-abstraction and rebound mech-
9
	  Figure 1: Starting structure for H-abstraction profile B-2. This structure was taken from
frame 577 of MD simulation 2 of docking pose B. The carbon atoms of mexiletine are
displayed in gray.
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Figure 2: QM/MM (B3LYP-D/CHARMM27) optimized reactant complex (RC) structures
for the (a) A-1, (b) B-1 and (c) C-1 reaction profiles.
anism steps in the quartet and doublet spin states. The barriers calculated with BSII are
provided in Table 1. Both steps in the mechanism show a wide range of values for the barrier
height, but the barrier to the rebound step is generally higher than that for the H-abstraction
step; the H-abstraction barriers vary from 6.9 to 17.8 kcal/mol, while the rebound barriers
range from 14.3 to 33.8 kcal/mol. The highest H-abstraction barriers are observed for the
models where the H-bond between one of the amine protons and Thr124 via a bridging water
molecule is not present (A-1, A-3 and C-1). The doublet and quartet barriers tend to be sim-
ilar for the hydrogen abstraction step, which is consistent with the small model DFT studies
of propan-2-amine hydroxylation,33,34 and also with QM and QM/MM studies of C-H ab-
straction from alkanes.59 The Boltzmann-weighted average barrier for the H-abstraction step
is 8.1 kcal/mol and is accessible to both the doublet and quartet spin states of Cpd I. This
barrier does not include a zero point energy (ZPE) correction; based on values calculated in
the small model studies,33,34 we expect this correction to be in the region of ∼ 3 kcal/mol.
This would result in a barrier of around 5.1 kcal/mol for the H-abstraction step. The free
energy barrier would be somewhat higher, because of activation entropy (see below), but it is
expected that this would be of similar magnitude to that of the competing mechanism. The
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rebound step has a Boltzmann-weighted average barrier of 15.0 kcal/mol, and is favored on
the doublet spin surface. A ZPE correction of 1.7 kcal/mol is estimated, based on previous
work,34 bringing the barrier down to approximately 13.3 kcal/mol.
Table 1: QM/MM barriers [in kcal/mol] for H-abstraction (∆E‡HAB) and rebound (∆E
‡
REB)
in the doublet (D) and quartet (Q) spin states (calculated with BSII). The profile labels
A, B and C denote the three different docked poses of mexiletine to the crystal structure
that were used as initial coordinates for molecular dynamics simulations (see SI for further
information).
Profile ∆E‡HAB ∆E
‡
REB
D Q D Q
A-1 17.4 15.4 14.3 18.4
A-2 14.4 14.9 18.5 21.3
A-3 17.8 17.7 22.8 33.8
B-1 14.2 15.0 16.8 26.3
B-2 6.9 7.2 16.0 20.1
B-3 8.6 14.9 14.4 27.5
B-4 10.3 14.7 15.5 26.0
B-5 8.3 8.3 21.7 25.5
C-1 15.9 14.6 14.4 14.9
∆E‡Ave 12.4 13.6 17.2 23.8
∆E‡B−Ave 8.1 8.4 15.0 16.2
The optimized geometries for the H-abstraction step are similar between the doublet and
quartet spin states for a given pathway. The QM geometries of the key intermediates for
the B-1 pathway are provided as representative examples in the SI. The transition state
to H-abstraction was observed at the same position on the potential energy surface for
all starting models (corresponding to an O−H distance of ∼ 1.2 A˚). During the rebound
step, not all of the pathways went to the hydroxamine product (2, Figure 3(a)): In the
case of the A-1, A-2, A-3, B-2 (all doublet+quartet) and B-3 (doublet only) pathways the
abstracted hydrogen spontaneously returns to the mexiletine nitrogen before the N−O bond
formation takes place, yielding the N-oxide product (Figure 3(b)). Hence, in this case, the
same intermediate is formed as that formed during the N -oxidation process. This alternative
process results in two separate barriers on the potential energy surface, the highest one (the
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return of the proton) is the one reported in Table 1. Large differences in barrier are observed
between the two spin surfaces for the rebound step. The doublet barriers are considerably
lower than those calculated for the quartet state, in some cases by more than 10 kcal/mol.
The preference for the doublet spin state during the rebound step is consistent with previous
work.33,34
The combined results for the H-abstraction/rebound mechanism show that this mecha-
nism favors the doublet spin surface and that the rate-limiting step is the rebound process.
The Boltzmann-weighted average barrier for this mechanism is approximately 13.3 kcal/mol.
Whilst some of the details of this mechanism are similar to those of the small model DFT
study of propan-2-amine oxidation,33,34 the present study shows that the rebound step is
rate-limiting, whereas in the most recent DFT study34 it was found that the H-abstraction
step was likely to be rate-limiting. However, the difference in energy barriers between the two
steps for propan-2-amine is small (less than 1 kcal/mol on the doublet spin surface), and the
overall energy barriers to the rebound step are very close in magnitude (within 1 kcal/mol).
As our QM/MM calculations include specific interactions with the protein/solvent environ-
ment, including the steric effects of the surrounding residues and the H-bonding interaction
with the water molecule bound to Thr124, this represents a more detailed model of the reac-
tion taking place. Furthermore, the previous work34 found that for other amine substrates,
the rebound steps were indeed rate-limiting.
Nine QM/MM reaction profiles were calculated for the direct N-oxidation mechanism,
from different initial starting geometries. The barriers are displayed in Table 2. As with the
H-abstraction/rebound mechanism, a wide range of barriers is observed. The BSII calculated
barriers range between 7.7 and 33.4 kcal/mol, with a Boltzmann-weighted average value of
9.0 kcal/mol on the doublet spin surface. The N−O bond formation step involves the transfer
of two electrons from the substrate to Cpd I. The transfer of the second electron requires
significantly more energy in the case of the quartet state, compared to the doublet. The
transition state for the doublet N-O bond formation step is earlier than that of the quartet
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(see SI), and corresponds to inversion at the nitrogen atom, rather than the electron transfer
step, which appears as a shoulder on the peak corresponding to the inversion step. This
finding is in good agreement with the previous small model study of propan-2-amine.33
Table 2: QM/MM barriers [in kcal/mol] for N-oxidation (∆E‡NOX) in the doublet (D) and
quartet (Q) spin states (calculated with BSII). The profile labels A, B and C denote the
three different docked poses of mexiletine to the crystal structure that were used as initial
coordinates for molecular dynamics simulations (see SI for further information).
Profile ∆E‡NOX
D Q
A-1 7.7 21.6
A-2 11.1 23.0
A-3 11.0 30.3
B-1 11.9 18.8
B-2 19.5 17.5
B-3 24.0 30.8
B-4 12.8 28.4
B-5 20.2 21.5
C-1 22.7 33.4
∆E‡Ave 15.7 25.0
∆E‡B−Ave 9.0 18.7
The Boltzmann-weighted average values of the BSII calculated reaction profiles for both
oxidation mechanisms are shown in Figure 4. The relative energies of all points on the
doublet potential energy surface are lower than the corresponding points on the quartet spin
surface. It is therefore likely that the doublet spin state is dominant for the N-hydroxylation
reaction of mexiletine as catalysed by CYP1A2. Previous calculations performed on the
N-hydroxylation of primary amines33 have found this to be the case for the N-oxidation
reaction, but similar barriers for the doublet and quartet spin states were reported for the
H-abstraction and rebound mechanism. Here we observed similar barriers for H-abstraction
between the doublet and quartet spin states, however, the doublet rebound barriers are
consistently lower than their quartet counterparts. The N-oxidation reaction is unfavorable
on the quartet spin surface compared to the doublet because the two electrons donated by
14
Figure 3: QM/MM (B3LYP-D/CHARMM27) optimized structures of (a) product of H-
abstraction followed by rebound, PHABS; (b) product of direct N-oxidation, PNOX .
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the substrate are of opposite spin, and for them to be accepted by the quartet spin state
of Cpd I requires that one of these electrons goes into a high energy unoccupied 3d orbital.
In contrast, this promotion is not required for the doublet spin state of Cpd I, as the two
electrons from the substrate can be accommodated by the singly occupied a2u and FeO pi*
orbitals, which contain electrons of opposite spin.60–62
The experimentally derived free energy barrier for the N-hydroxylation of mexiletine in
CYP1A2 (at 310 K), derived using transition state theory63,64 from a reported experimen-
tally measured turnover number of 110 pmoles/nmole P450/min,26 is 21.3 kcal/mol. This
is significantly higher than our Boltzmann-weighted average barriers for either mechanism
(and also the case if simple averaging of the energy barriers is used). There are several
possible reasons for this difference. Firstly, the calculated barriers quoted here are not free
energy barriers (unlike the experimental value) and therefore do not include entropic ef-
fects, which are expected to raise the barrier by ∼ 3 kcal/mol, based on calculations of
similar reactions.65,66 This should always be considered when comparing potential energy
barriers with apparent free energy barriers derived from experimental kinetic measurements.
Also there can be additional free energy penalties for conformational changes and reactions
may proceed via minor, higher energy binding modes or conformations.12 Secondly, it is
not established which step in the catalytic cycle is rate-determining for the N-hydroxylation
reaction; previous studies on a number of different systems have shown a variety of steps to
be rate-limiting for CYPs, including the second electron transfer step, the C−H bond break-
ing step for aliphatic oxidation, and an unidentified step between product formation and
release.67 For this reason, the N-hydroxylation reaction barrier may not necessarily be the
same as the reaction barrier for the whole catalytic cycle. Thirdly, DFT calculated barriers
are sometimes (but not always) too low by several kcal/mol.68 Further discrepancies can be
due to artefacts associated with QM/MM methods.69 Finally, contributions from tunnelling
are also often an important consideration when modeling H-atom transfer.70
A further important factor to consider is the contribution of the binding of the substrate
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Figure 4: Reaction profiles for direct N-oxidation and H-abstraction/rebound mechanisms.
Energies of all species [in kcal/mol] are Boltzmann-weighted average values calculated at the
B3LYP-D-6-311++G(d,p)/CHARMM27 level of QM/MM theory.
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into a reactive position to the overall barrier. The averaging of barriers using a Boltzmann
weighting will not take into account the fact that different substrate conformations may be
more of less prevalent, for example it is not known to what extent conformations A, B and
C differ in binding free energy. Hence the true overall barrier will reflect both the barrier to
reaction and the free energy of binding of the substrate in the respective reactive orientation.
We have found this to be the case previously for oxidation of diclofenac in CYP2C9, where
a higher barrier process is favored over a lower barrier process due to the Michaelis complex
having a more favorable binding free energy in the former.12 However, in the present case, the
substrate binding conformations are very similar to each other. Therefore, it is reasonable
here to make comparisons based on energy barriers alone.
Conclusions
In the current study, the mechanism for the oxidation of primary amines has been investi-
gated using a large and detailed enzyme-substrate model, in which the effects of the surround-
ing enzyme environment are included explicitly. Two mechanisms have been proposed31 for
the N-hydroxylation of mexiletine, catalysed by CYP1A2: direct N-oxidation, and hydrogen
abstraction followed by rebound. The two mechanisms were modeled for the doublet and
quartet spin states of Cpd I using QM/MM, and the direct nitrogen oxidation mechanism
was found to be more energetically favorable. These results differ somewhat from a recent
small model DFT study where simpler primary amines were used as substrates.34 However,
in the previous study, the relative difference in barrier between the two mechanisms varied
depending on the substrate in question. It is therefore possible that the two mechanisms
compete in nature, with N-oxidation being favored for this particular substrate. For both
mechanisms, the reaction barriers were found to be lower in energy for the doublet spin state
of Cpd I, than for the quartet spin state, with a more pronounced effect observed for the
N-oxidation mechanism.
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A wide range of values is observed here for the reaction barriers for each mechanism
and spin state. This is due to the use of a variety different starting geometries, despite
pre-screening of molecular dynamics (MD) snapshots. A Boltzmann-weighted averaging
procedure was used to ensure that the lowest, and therefore most relevant values are given
a greater weighting. It is well accepted that in order to obtain reliable results, an ade-
quately sized ensemble of starting geometries must be used.39 Ideally, many more reaction
profiles would have been calculated for each mechanism and spin state, however this is not
practical due to the high computational cost of running such QM/MM calculations. This
makes the pre-screening of snapshots and the selection of suitable geometric criteria of great
importance.39,71
A series of MD simulations was carried out in order to find reactive conformations of
mexiletine within the active site. The presence of a single water molecule was found to
play a large role on keeping mexiletine in a reactive position within the active site. When
significantly more water molecules (> 5) were present, mexiletine was displaced from a
reactive position. A bridging water molecule was observed between the mexiletine and
Thr124, orienting the mexiletine in a reactive conformation throughout the simulation. The
water molecule is not a prerequisite for mexiletine binding, however, in simulations where
a single water molecule was present, mexiletine remained in a reactive conformation for a
larger proportion of the simulation than when the water molecule was absent. A pi-stacking
interaction was observed between the substrate and Phe226, in all of the transition state
structures, whether or not a water molecule was present.
Increased knowledge of cytochrome P450 activity and mechanisms gained through studies
such as this should be useful in improving drug reactivity and metabolism prediction, as well
as increasing their applications in biocatalysis.9,12,14
19
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